Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Leitner

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|August 14, 2023
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and VarlilumabJudith Leitner, Ricarda Egerer, Petra Waidhofer-Söllner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2024
Inhibitory CARs fail to protect from immediate T cell cytotoxicityMaximilian A Funk, Gerwin Heller, Petra Waidhofer-Söllner, et al.
Immunology Letters|July 16, 2011
The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signalsJudith Leitner, Karin Drobits, Winfried F Pickl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2015
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T CellsJudith Leitner, Dietmar Herndler-Brandstetter, Gerhard J Zlabinger, et al.
Plos Pathogens|April 5, 2013
TIM-3 does not act as a receptor for galectin-9Judith Leitner, Armin Rieger, Winfried F Pickl, et al.
Frontiers in Immunology|September 9, 2022
BTLA inhibition has a dominant role in the <i>cis</i>-complex of BTLA and HVEMClaire Battin, Judith Leitner, Petra Waidhofer-Söllner, et al.
Health Science Reports|May 6, 2026
Mechanistic Explanations of Manual Therapy Do Not Influence Outcomes in Healthy Individuals: A Randomized Controlled TrialSofie Waesch, Judith Leitner, Lisa M Stelzer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 16, 2014
STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cellsKlaus G Schmetterer, Alina Neunkirchner, Daniela Wojta-Stremayr, et al.
Veterinary Immunology and Immunopathology|February 17, 2012
Porcine SWC1 is CD52--final determination by the use of a retroviral cDNA expression libraryJudith Leitner, Katharina Reutner, Sabine E Essler, et al.
European Journal of Immunology|November 12, 2020
4-1BB costimulation promotes bystander activation of human CD8 T cellsManuel Reithofer, Sandra Rosskopf, Judith Leitner, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|August 14, 2023
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and VarlilumabJudith Leitner, Ricarda Egerer, Petra Waidhofer-Söllner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2024
Inhibitory CARs fail to protect from immediate T cell cytotoxicityMaximilian A Funk, Gerwin Heller, Petra Waidhofer-Söllner, et al.
Immunology Letters|July 16, 2011
The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signalsJudith Leitner, Karin Drobits, Winfried F Pickl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2015
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T CellsJudith Leitner, Dietmar Herndler-Brandstetter, Gerhard J Zlabinger, et al.
Plos Pathogens|April 5, 2013
TIM-3 does not act as a receptor for galectin-9Judith Leitner, Armin Rieger, Winfried F Pickl, et al.
Frontiers in Immunology|September 9, 2022
BTLA inhibition has a dominant role in the <i>cis</i>-complex of BTLA and HVEMClaire Battin, Judith Leitner, Petra Waidhofer-Söllner, et al.
Health Science Reports|May 6, 2026
Mechanistic Explanations of Manual Therapy Do Not Influence Outcomes in Healthy Individuals: A Randomized Controlled TrialSofie Waesch, Judith Leitner, Lisa M Stelzer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 16, 2014
STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cellsKlaus G Schmetterer, Alina Neunkirchner, Daniela Wojta-Stremayr, et al.
Veterinary Immunology and Immunopathology|February 17, 2012
Porcine SWC1 is CD52--final determination by the use of a retroviral cDNA expression libraryJudith Leitner, Katharina Reutner, Sabine E Essler, et al.
European Journal of Immunology|November 12, 2020
4-1BB costimulation promotes bystander activation of human CD8 T cellsManuel Reithofer, Sandra Rosskopf, Judith Leitner, et al.
Pageof 8